Summary Abiomed, Inc. (Abiomed) is a provider of mechanical circulatory support devices. It undertakes the development, manufacture and marketing of novel technologies designed to replace or assist the pumping function of the failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; as well as percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offer automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It manufactures products in Danvers, Massachusetts; and Aachen, Germany. Abiomed is headquartered in Danvers, Massachusetts, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Abiomed, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Abiomed, Inc. Company Snapshot 5 Abiomed, Inc. Company Overview 5 Abiomed, Inc. Pipeline Products and Clinical Trials Overview 6 Abiomed, Inc. - Pipeline Analysis Overview 8 Business Description 8 Key Facts 8 Abiomed, Inc. - Major Products and Services 9 Abiomed, Inc. Pipeline Products by Development Stage 10 Abiomed, Inc. Pipeline Products Overview 12 AbioCor II 12 AbioCor II Product Overview 12 Impella 5.5 13 Impella 5.5 Product Overview 13 Impella BTR 14 Impella BTR Product Overview 14 Impella ECP 15 Impella ECP Product Overview 15 Next Generation Impella CP 16 Next Generation Impella CP Product Overview 16 Symphony Heart Pump 17 Symphony Heart Pump Product Overview 17 Abiomed, Inc. - Key Competitors 18 Abiomed, Inc. - Key Employees 19 Abiomed, Inc. - Key Employee Biographies 20 Abiomed, Inc. - Locations And Subsidiaries 21 Head Office 21 Other Locations & Subsidiaries 21 Recent Developments 23 Abiomed, Inc., Recent Developments 23 May 03, 2016: Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year 23 Apr 12, 2016: Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park 23 Apr 07, 2016: Abiomed Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery 24 Feb 08, 2016: Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors 25 Feb 04, 2016: Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year 26 Jan 11, 2016: Abiomed Announces Preliminary Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year 27 Oct 29, 2015: Abiomed Announces Q2 FY 2016 Revenue of $76.4 Million, Up 47% Over Prior Year 27 Oct 08, 2015: Abiomed to Appoint Seth Bilazarian, M.D., New Vice President of Interventional Cardiology Programs 28 Oct 08, 2015: Abiomed's Impella Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions 28 Aug 04, 2015: Abiomed Announces Q1 FY 2016 Revenue of $73.4 Million, Up 50% Over Prior Year 29 Appendix 31 Methodology 31 About GlobalData 31 Contact Us 31 Disclaimer 31
List of Tables
Abiomed, Inc. Pipeline Products and Clinical Trials Overview 6 Abiomed, Inc. Pipeline Products by Equipment Type 6 Abiomed, Inc. Pipeline Products by Indication 7 Abiomed, Inc., Key Facts 8 Abiomed, Inc., Major Products and Services 9 Abiomed, Inc. Number of Pipeline Products by Development Stage 10 Abiomed, Inc. Pipeline Products Summary by Development Stage 11 AbioCor II - Product Status 12 AbioCor II - Product Description 12 Impella 5.5 - Product Status 13 Impella 5.5 - Product Description 13 Impella BTR - Product Status 14 Impella BTR - Product Description 14 Impella ECP - Product Status 15 Impella ECP - Product Description 15 Next Generation Impella CP - Product Status 16 Next Generation Impella CP - Product Description 16 Symphony Heart Pump - Product Status 17 Symphony Heart Pump - Product Description 17 Abiomed, Inc., Key Employees 19 Abiomed, Inc., Key Employee Biographies 20 Abiomed, Inc., Subsidiaries 21
List of Figures
Abiomed, Inc. Pipeline Products by Equipment Type 7 Abiomed, Inc. Pipeline Products by Development Stage 10
Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to drivRead More...
Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing apRead More...
Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected toRead More...
Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast periodRead More...
Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive tRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.